Back to search

Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis

Data up to Jan 2025

Published2004
Citations26
References27

Total Citations Per Year

Abstract

References (27)

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1976 • 200,127 citations

Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34

1997 • 1,613 citations

Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs

2001 • 947 citations

The Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation

2001 • 542 citations

Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)

1994 • 456 citations

Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer

2003 • 339 citations

Overview of matrix metalloproteinase expression in cultured human cells

1998 • 259 citations

Tuberous sclerosis complex: a review of neurological aspects

2002 • 211 citations

Tuberous sclerosis complex

2000 • 206 citations

ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis

2001 • 181 citations

Novel Regulation of Type IV Collagenase (Matrix Metalloproteinase-9 and -2) Activities by Transforming Growth Factor-β1 in Human Prostate Cancer Cell Lines

1999 • 163 citations

Matrix Metalloproteinase Disruption of the Extracellular Matrix and Cardiac Dysfunction

2002 • 120 citations

Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate

1995 • 103 citations

Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms

2002 • 82 citations

Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.

1997 • 74 citations

Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells

1999 • 74 citations

Tuberous sclerosis complex

2004 • 59 citations

Tuberous sclerosis gene products in proliferation control

2001 • 54 citations

Treatment of angiofibromas with a scanning carbon dioxide laser: A clinicopathologic study with long-term follow-up

2001 • 48 citations

Evidence for the Tissue Inhibitor of Metalloproteinases‐1 (TIMP‐1) in Human Polymorphonuclear Leukocytes

1995 • 32 citations

Effect of parathyroid hormone‐related protein on fibroblast proliferation and collagen metabolism in human skin

2002 • 25 citations

Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.

2001 • 24 citations

Clinical features of tuberous sclerosis cases.

2002 • 15 citations

Types I and III collagens and the activities of prolyl hydroxylase and galactosylhydroxylysyl glucosyltransferase in skin lesions of tuberous sclerosis

1982 • 11 citations

CHEMICAL ANALYSIS OF AN ANGIOFIBROMA FROM A PATIENT WITH TUBEROUS SCLEROSIS

1977 • 8 citations

Immunohistochemical and biochemical studies on collagen types in angiofibromas and shagreen patches from patients with tuberous sclerosis

1982 • 5 citations

Cited By (0)

Loading...
Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin… (2004) – Journal of the American Academy of Dermatology | Metascience Observatory Explorer